Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

PURPOSE: Transitional cell carcinoma (TCC) is a pan-urothelial disease characterized by multiplicity. Although little is known about the molecular events in upper-tract TCC, similar carcinogenic mechanisms are thought to occur throughout the urinary tract. However, we have previously shown that dis...

Full description

Bibliographic Details
Main Authors:	Catto, J, Azzouzi, A, Rehman, I, Feeley, K, Cross, S, Amira, N, Fromont, G, Sibony, M, Cussenot, O, Meuth, M, Hamdy, F
Format:	Journal article
Language:	English
Published:	2005

Similar Items

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
by: Catto, J, et al.
Published: (2003)

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder
by: Yates, DR, et al.
Published: (2006)

Promoter hypermethylation identifies progression risk in bladder cancer.
by: Yates, DR, et al.
Published: (2007)

Behavior of urothelial carcinoma with respect to anatomical location.
by: Catto, J, et al.
Published: (2007)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
by: Rouprêt, M, et al.
Published: (2008)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression
by: Roupret, M, et al.
Published: (2008)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
by: Roupret, M, et al.
Published: (2004)

Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas
by: Ahmad, M, et al.
Published: (2003)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
by: Rouprêt, M, et al.
Published: (2005)

A comparative analysis of the behaviour of urothelial carcinoma with respect to anatomical location
by: Catto, J, et al.
Published: (2007)

Clinically localised prostate cancer is microsatellite stable.
by: Azzouzi, A, et al.
Published: (2007)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
by: Rehman, I, et al.
Published: (2004)

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
by: Rehman, I, et al.
Published: (2004)

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors.
by: Rehman, I, et al.
Published: (2004)

DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target
by: Catto, J, et al.
Published: (2006)

Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.
by: Leiblich, A, et al.
Published: (2006)

Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer
by: Catto, J, et al.
Published: (2006)

Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis
by: Rehman, I, et al.
Published: (2003)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
by: van Oers, J, et al.
Published: (2009)

Genetic instability and transitional cell carcinoma of the bladder.
by: Catto, J, et al.
Published: (2004)

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
by: Dhawan, D, et al.
Published: (2006)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
by: Roupret, M, et al.
Published: (2007)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
by: Yates, DR, et al.
Published: (2006)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
by: Yates, DR, et al.
Published: (2005)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
by: Roupret, M, et al.
Published: (2007)

The use of proteomics in urological research
by: Rehman, I, et al.
Published: (2005)

Tissue microarray immunohistochemistry and cluster analysis confirms the validity of candidate proteins in prostate cancer identified by proteomic analysis of urine
by: Rehman, I, et al.
Published: (2005)

Gli1 appears to be constitutively expressed in the lumenal epithelial cells of the prostate but not in the basal cell layer or the mesenchyme
by: Spencer, A, et al.
Published: (2004)

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
by: Catto, J, et al.
Published: (2003)

Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer.
by: Dudziec, E, et al.
Published: (2011)

Loss of intercellular expression of beta-dystroglycan is a common event in prostate cancer and is significantly associated with loss of differentiation
by: Cross, S, et al.
Published: (2005)

Epigenetic changes in urothelial cancer: A feature of the invasive phenotype and a novel therapeutic target
by: Catto, J, et al.
Published: (2006)

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
by: Rehman, I, et al.
Published: (2005)

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
by: Rehman, I, et al.
Published: (2004)

The role of genetic instability in the pathogenesis and progression of urothelial carcinoma
by: Catto, J, et al.
Published: (2005)

PER3 promoter hypermethylation correlates to the progression of pan-cancer
by: Yaoxu Li, et al.
Published: (2024-10-01)

Inactivation of the hypermethylated in cancer 1 tumour suppressor – not just a question of promoter hypermethylation?
by: M Jenal, et al.
Published: (2010-10-01)

[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract].
by: Burger, M, et al.
Published: (2006)

Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract
by: Burger, M, et al.
Published: (2006)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
by: Rehman, I, et al.
Published: (2008)